Grunenthal, Horizon sign commercialization contract for Duexis in Latin America
Duexis is a proprietary single-tablet combination of the NSAID ibuprofen and the histamine H2-receptor antagonist famotidine. The product is indicated for the relief of signs and symptoms of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.